Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $79.80 USD
Change Today +2.16 / 2.78%
Volume 381.0K
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
OTC US
OTC US
OTC US
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert B. Stein M.D., Ph.D.

Former Executive Officer, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 7 different industries.

See Board Relationships
63$1,572,507

Background*

Dr. Robert B. Stein, also known as Bob, M.D., Ph.D., has been Chief Scientific Officer at Agenus Inc. since February 2014. Dr. Stein serves as scientific adviser to Takeda Pharmaceutical Co. Ltd. Dr. Stein has over 30 years of experience and accomplishments to the Agenus leadership team. He is an innovative and experienced executive with deep, broad knowledge of biology, medicine and pharmaceutical science. Dr. Stein lead Agenus' Research, Pre-clinical Development and ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

Former Director
1996-2003
Former Director
2001-N/A
Former President, Chief Scientific Officer and Director
2007-Present
Director
2008-N/A
Former Chief Executive Officer and Director

Education*

PhD
Duke University
MD
Duke University
BS
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

Salary$323,827
Total Annual Compensation$323,827

Stock Options*

All Other Compensation$141,615
Unexercisable Options350,000
Unexercisable Options Value$318,500
Total Value of Options$318,500
Total Number of Options350,000

Total Compensation*

Total Annual Cash Compensation$765,442
Total Short Term Compensation$323,827
Other Long Term Compensation$141,615
Total Calculated Compensation$1,572,507
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $79.80 USD +2.16

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.